CN107630087A - For detecting primer, probe and the kit of 1394 mutation of C-KIT genes - Google Patents
For detecting primer, probe and the kit of 1394 mutation of C-KIT genes Download PDFInfo
- Publication number
- CN107630087A CN107630087A CN201610562717.4A CN201610562717A CN107630087A CN 107630087 A CN107630087 A CN 107630087A CN 201610562717 A CN201610562717 A CN 201610562717A CN 107630087 A CN107630087 A CN 107630087A
- Authority
- CN
- China
- Prior art keywords
- kit
- mutation
- probe
- detection
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a kind of primer, probe and kit for being used to detect 1394 mutation of C KIT genes.The primer is as shown in SEQ ID No.1 SEQ ID No.2, and the probe is as shown in SEQ ID No.3.Real-time fluorescence PCR is carried out using the kit of the present invention, 1394 C of C KIT genes can be detected and replace with G mutation.
Description
Technical field
The present invention relates to biological technical field, specifically, is related to a kind of for detecting C-KIT
Primer, probe and the related kit of gene mutation.
Background technology
C-KIT is a kind of proto-oncogene, positioned at chromosome 4q11-12, total length about 80kb.C-KIT
The C-KIT albumen of coding belongs to type III receptor tyrosine kinase family member, it be molecular weight about
For 145KD transmembrane protein, EGFR-TK area, transmembrane region and the part knot of intracellular are contained
Close site extracellular region.Itself protein tyrosine kinase activity can be activated after part is in connection,
Downstream signal transduction path is activated by series reaction, so as to adjust the growth of cell and propagation.
Gastrointestinal stromal tumor (GIST) is most common leaf source property tumour of alimentary canal.Research shows,
C-KIT gene mutation rates are about 90% in GIST patient.
Sanger PCR sequencing PCRs are the main methods of C-KIT detection in Gene Mutation at present.However, should
The sensitivity of method is low, can cause missing inspection and the generation of false negative, and detection time is grown, nothing
Method meets the actual demand of clinical detection.Clinically there is an urgent need to develop a kind of high sensitivity, fast
The C-KIT detection in Gene Mutation technologies of speed.
The present inventor is found that in gastrointestinal stromal tumor (GIST) routine testing and stomach
Intestinal Stromal Tumors are relevant to dash forward positioned at the new mutation site of C-KIT genes, i.e. 1394 C > G
Become.The present inventor develops a kind of quick, highly sensitive, easy to operate for the mutation
Detection kit and correlation detection method, can be used for GIST chemotherapy prognosis.
The content of the invention
It is an object of the invention to provide a kind of primer and spy for being used to detect C-KIT gene mutations
Pin, the mutation is that 1394 C replace with G (base mutations:1394C > G, protein mutation:
S465C).The primer of the present invention includes following sequence with probe:
Forward primer (F):GATGTGCAGACACTAAACTCACG(SEQ ID No:1)
Reverse primer (R):GCACTAGAATCTATAGAACTCTGAAC(SEQ ID
No:2)
Probe (PB):TGGGCCACCGTTTGGAAAGCTAG(SEQ ID No:3)
Another aspect of the present invention provides a kind of detection for being used to detect 1394 mutation of C-KIT genes
Kit, the kit include SEQ ID No.1-SEQ ID No.2 shown in primer and
Probe shown in SEQ ID No.3.
According to used PCR method, kit of the invention can also include reference gene and
Internal control gene.
Another aspect of the present invention provides a kind of method of 1394 mutation of detection C-KIT genes, its
Comprise the following steps:
(1) genomic DNA in sample is extracted, detection sample includes fresh pathological tissue, paraffin
Investing tissue, whole blood and blood plasma etc.;
(2) DNA is expanded with the kit of the present invention;
(3) the Ct values shown according to fluorescent PCR instrument judge testing result:Detect reaction system
FAM fluorescence intensities, the cycle-index Ct values for reaching required during the threshold value of setting with FAM are made
It is feminine gender for negative, Positive judgement standards, Ct values > 38 or without amplification, Ct value≤38 are the positive.
, can be with specific detection C-KIT bases present invention employs specific primer and probe technique
Because of mutation.The method high sensitivity, high specificity, detection speed are fast.
Brief description of the drawings
Fig. 1 is the PCR figures of detection negative sample (wild type).
Fig. 2 is the PCR figures of detection mutation positive sample.
Embodiment
With reference to specific embodiment, the present invention is expanded on further.It should be understood that these are implemented
Example is only used for the present invention rather than limitation the scope of the present invention.Unreceipted specific bar in embodiment
The experimental method of part, according to normal condition well known to those skilled in the art, or according to manufacture
Condition recommended by the manufacturer.
One, principles
After the specific primer of the present invention is combined with probe with DNA profiling, Taq archaeal dna polymerases
With deoxynucleotide (dNTP) for substrate, to reference gene (Internal Reference, IR) and
C-KIT genic mutation types gene carries out amplification in vitro.Detection uses Fluorescence PCR assay, passes through
Specific probe hydrolysis release fluorescence, the progress of monitoring PCR reactions, determines that C-KIT genes are dashed forward
Change situation.
The kit of the present invention has been separately provided reference gene detection architecture.Reference gene is difference
In the house-keeping gene of C-KIT genes to be checked.By the amplification situation (FAM for detecting reference gene
Passage), can analyze whether DNA to be checked can normally be expanded, so as to exclude DNA purity,
Concentration is bad, or the situation of PCR detection failures is caused containing PCR inhibitor etc..
The kit of the present invention is provided with internal control simultaneously in C-KIT genic mutation type detection architectures
Gene (Internal Control, IC) detection architecture.Two kinds of systems in same PCR pipe simultaneously
Reacted.Internal control gene is also the house-keeping gene for being different from gene C-KIT to be checked.Will identification
The probe modification of C-KIT gene mutation templates is FAM fluorophors, and will identify internal control gene
The probe modification of template is HEX fluorophors.By detecting internal control gene magnification situation (HEX
Passage), it can analyze whether DNA to be checked can normally be expanded, so as to exclude Lou reagent adding or sample
Originally, sample contains the situation that PCR inhibitor etc. causes PCR detection failures.
When carrying out the judgement of this kit testing result, FAM, HEX lead in negative quality-control product (NC)
Road detection all should be without amplification (not in typical S types curve.Note:Typical S types curve is successively
Show as exponential phase, straight line phase and plateau) or without Ct values, FAM in positive quality control product (PC),
HEX Air conduct measurements should have amplification (being in typical S types curve) and Ct value≤28;Otherwise recognize
It is invalid to test, it need to repeat to test.
Two, experiment materials and equipment
1. for mutational site design synthesis specific primer and probe
Special primer and probe are designed for C-KIT gene mutation sites.Pass through specific primer
And probe optimization, to realize highly sensitive and quick detection.
Primer and probe after optimization is as follows:
Forward primer (F):GATGTGCAGACACTAAACTCACG(SEQ ID No:1)
Reverse primer (R):GCACTAGAATCTATAGAACTCTGAAC(SEQ ID
No:2)
Probe (PB):TGGGCCACCGTTTGGAAAGCTAG(SEQ ID No:3)
2. detect sample process and DNA extraction
It can be fresh pathological tissue, paraffin-embedded tissue, whole blood, blood plasma and abdomen to detect sample
Chamber hydrops.Only illustrated below by taking paraffin-embedded tissue sample as an example.
Before sample collection, patient is without tyrosine kinase inhibitor (tyrosine kinase
Inhibitors, TKIs) class drug therapy;Because DNA sample quality can influence testing result, because
This, which should determine that, contains cancerous tissue cell in the paraffin-embedded tissue sample in DNA sample source, and
No less than the 25% of whole sample;And DNA sample OD260/OD280=1.8 ± 0.2,
OD260/OD230≥1.7;Concentration is 5-10ng/ μ l.
Conserving time limit is no more than 12 months paraffin-embedded tissue sample at room temperature, after extraction
DNA sample conserving time limit under -20 DEG C of freezing conditions is no more than 6 months.
3. it is applicable instrument
Stratagene Mx3000P。
4. the composition of kit
Kit forms are shown in Table 1.Nucleic acid extraction composition is free of in kit, uses QIAamp
(Qiagen companies produce DNA FFPE Tissue Kit, article No.:56404) kit completes stone
The sample DNA extraction of wax investing tissue.Detection reagent forms and C-KIT genes mutational site to be checked
It is shown in Table 2.IR detection reagents are containing only reference gene detection architecture (FAM passages), C-KIT inspections
Test agent is examined containing C-KIT detection in gene mutation system (FAM passages) and internal control gene simultaneously
Survey system (HEX passages).
Table 1:Kit forms
The particular sequence of wherein described reference gene and internal control gene can be by those skilled in the art
It is readily determined according to experimental conditions or is provided by Beijing Yakangbo Biotechnology Co., Ltd..
Three, detection methods
1. QIAamp DNA FFPE Tissue Kit (production of Qiagen companies) kit is used,
Paraffin-embedded tissue sample DNA extraction is carried out according to operation instructions.
2. take the detection reagent and positive quality control product (PC) in kit.Test agent and sun to be checked
Property quality-control product PC melt after of short duration centrifugation, be placed on ice.
3. volume ratio mixing IR detection reagents and Taq archaeal dna polymerases by 17: 0.3, are pressed
17: 0.3 volume ratio mixing C-KIT detection reagents and Taq archaeal dna polymerases.By 17.3/
Hole dispenses IR detection reagents and C-KIT detection reagents into eight connecting legs.Tried to being detected equipped with IR
2.7 μ l DNA samples to be checked, feminine gender are separately added into eight connecting legs of agent and C-KIT detection reagents
Quality-control product (NC, the buffer solution of dissolving DNA, provided for oneself by user) and positive quality control product PC,
Piping and druming mixes, and covers tightly of short duration centrifugation after lid.Pay attention to:Vortex oscillation instrument is not used during mixing;
Subsequent operation is carried out after mixing immediately.
4. the setting of fluorescent PCR instrument sense channel needs simultaneous selection FAM, HEX passage (reference
Dyestuff is arranged to "None").Response procedures are set following (table 2):
Table 2:
The explanation of four, testing results
1.Ct values determine:The baseline of Stratagene MX3000P fluorescent PCR instrument is set first:
Fluorescence signal during selection " being adapted to baseline (Adaptive baseline) " setting, threshold value (threshold)
Setting principle is (random to make an uproar just above normal negative quality-control product NC amplification curves with threshold line
Sound line) peak, even negative quality-control product NC amplification curves show that " No Ct " are defined.
Ct value of each sample in each site primer is read from software.
2. qualitative analysis:
(1) quality of experiments is judged:If FAM, HEX Air conduct measurement (are not in without amplification in NC
Typical S type curves.Note:Typical S types curve show as successively exponential phase, the straight line phase and
Plateau) or without Ct values, in PC, FAM, HEX Air conduct measurement have amplification (is in typical S
Type curve) and Ct value≤28, then it can continue to analyze;Otherwise it is assumed that experiment is invalid, need to repeat real
Test.
(2) reference gene (IR) detection case is judged in DNA sample to be checked:If reference gene detects
(FAM passages) has amplification and 19≤Ct value≤25, then can continue to analyze;If its Ct value is smaller,
Then think DNA sample excessive concentration;If its Ct value is larger or without amplification, then it is assumed that DNA samples
Product concentration is too low, degrades, or may wherein contain PCR inhibitor.
(3) internal control genetic test situation is judged in DNA sample to be checked:If internal control genetic test
(HEX passages) has amplification and Ct value≤25, then can continue to analyze;If internal control genetic test (HEX
Passage) Ct values are larger or without amplification, but mutational site detection (FAM passages) have amplification and
Ct value≤38, then can continue analysis (may produce because mutational site expands to internal control gene magnification
Suppress);Internal control genetic test if (HEX passages) Ct values are larger or without amplification, and are mutated position
Point detection (FAM passages) can not then continue to analyze without expanding or having amplification but Ct values > 38,
Need to repeat experiment (degraded may occur due to DNA sample, wherein containing PCR inhibitor or
Product are not loaded).
(4) gene mutation situation is judged in DNA sample to be checked:If certain mutational site is detected in sample
(FAM passages) has amplification and Ct value≤38, then judges that sample mutation result is the positive;If
Ct values > 38 or without amplification, then judge that sample mutation result is feminine gender.
Pay attention to:Various mutations are may be simultaneously present in same DNA sample.
Fig. 1 is the PCR figures that testing result is negative sample (wild type sample), and Fig. 2 is
Testing result is schemed for the PCR of positive sample (saltant type sample).
Pass through contrasting detection, it was demonstrated that fluorescence PCR method of the invention and the knot of traditional sequencing methods
Fruit is consistent, and the sensitivity of the fluorescence PCR method of the present invention and selectivity are higher than conventional measurement
Sequence method.
Therefore, Fluorescence PCR system of the present invention can detect 1394 C of C-KIT genes and replace
G mutation are changed to, easy to detect quick, accuracy is high, can meet that C-KIT gene mutations are quick
The requirement of detection.
Claims (5)
- A kind of 1. primer for being used to detect 1394 mutation of C-KIT genes, it is characterised in that The primer is as shown in SEQ ID No.1-SEQ ID No.2.
- A kind of 2. probe for being used to detect 1394 mutation of C-KIT genes, it is characterised in that The probe is as shown in SEQ ID No.3.
- A kind of 3. kit for being used to detect 1394 mutation of C-KIT genes, it is characterised in that The kit includes the primer and SEQ ID No. shown in SEQ ID No.1-SEQ ID No.2 Probe shown in 3.
- 4. kit as claimed in claim 3, it is characterised in that it also includes reference gene With internal control gene.
- 5. a kind of method of 1394 mutation of detection C-KIT genes, it comprises the following steps:(1) genomic DNA in sample is extracted;(2) DNA is expanded with the kit described in claim 3;(3) the Ct values shown according to fluorescent PCR instrument judge testing result.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610562717.4A CN107630087A (en) | 2016-07-18 | 2016-07-18 | For detecting primer, probe and the kit of 1394 mutation of C-KIT genes |
PCT/CN2017/000444 WO2018014519A1 (en) | 2016-07-18 | 2017-07-14 | Primer, probe and kit used for detecting c-kit gene mutation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610562717.4A CN107630087A (en) | 2016-07-18 | 2016-07-18 | For detecting primer, probe and the kit of 1394 mutation of C-KIT genes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107630087A true CN107630087A (en) | 2018-01-26 |
Family
ID=61112721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610562717.4A Pending CN107630087A (en) | 2016-07-18 | 2016-07-18 | For detecting primer, probe and the kit of 1394 mutation of C-KIT genes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107630087A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015116868A2 (en) * | 2014-01-29 | 2015-08-06 | Caris Mpi, Inc. | Molecular profiling of immune modulators |
CN105112500A (en) * | 2015-06-29 | 2015-12-02 | 北京雅康博生物科技有限公司 | Primers, probe and kit for detecting C-KIT gene mutation |
-
2016
- 2016-07-18 CN CN201610562717.4A patent/CN107630087A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015116868A2 (en) * | 2014-01-29 | 2015-08-06 | Caris Mpi, Inc. | Molecular profiling of immune modulators |
CN105112500A (en) * | 2015-06-29 | 2015-12-02 | 北京雅康博生物科技有限公司 | Primers, probe and kit for detecting C-KIT gene mutation |
Non-Patent Citations (1)
Title |
---|
白辰光等: ""胃肠道间质瘤临床病理分级及基因分型的研究进展"", 《胃肠道间质瘤临床病理分级及基因分型的研究进展》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105112500B (en) | A kind of primer, probe and kit for being used to detect C-KIT gene mutations | |
CN107949642B (en) | Compositions and methods for screening for solid tumors | |
CN107868828A (en) | Detect the specific primer probe composition and kit and detection method in EGFR gene T790M sites | |
CN110055312B (en) | Primer, probe and kit for detecting cis-trans mutation of EGFR gene C797S and T790M | |
CN107345253A (en) | Lung cancer clinical medication genetic test standard items and its application | |
CN107523617A (en) | The standard items of intestinal cancer clinical drug-resistant genetic test and its application | |
CN104017887A (en) | Primer pair as well as probe and kit for detecting human BRAF gene mutation | |
CN108342461A (en) | DdPCR technologies detect primer, kit and the detection method of IDH1 genetic mutations | |
CN107723362A (en) | For detecting primer, probe and the kit of 1,675 1681 mutation of C KIT genes | |
CN107630089A (en) | For detecting primer, probe and the kit of the mutation of C-KIT gene 1689-1718 positions | |
CN107739757A (en) | For detecting primer, probe and the kit of 37 1738 mutation of C KIT gene 17s | |
CN106636376A (en) | Nucleic acid and kit for detecting human ROS1 fusion genes and application method of kit | |
CN106319035A (en) | Primer, probe and kit for detection of C-KIT gene mutation | |
CN107723361A (en) | For detecting primer, probe and the kit of 1,654 1689 mutation of C KIT genes | |
CN107723360A (en) | For detecting primer, probe and the kit of 37 1738 mutation of C KIT gene 17s | |
CN110144386A (en) | For detecting the primer, probe and kit of POLE gene mutation | |
CN109593856A (en) | A kind of kit and preparation method thereof of detection 2 codon 12/13 of KRAS gene extron mutation | |
CN106319034A (en) | Primer, probe and kit for detection of C-KIT gene mutation | |
CN107630087A (en) | For detecting primer, probe and the kit of 1394 mutation of C-KIT genes | |
CN107630088A (en) | For detecting primer, probe and the kit of the mutation of C-KIT gene 1648-1686 positions | |
CN107586851A (en) | A kind of KRAS, NRAS, BRAF gene mutation detection kit | |
CN106011298A (en) | ApoE kit, primers and use thereof | |
WO2017000534A1 (en) | Primer, probe, and reagent kit used for detecting c-kit gene mutation | |
CN107630090A (en) | For detecting primer, probe and the kit of 03 1724 mutation of C KIT gene 17s | |
CN111705132A (en) | Primer probe set, kit and method for detecting liver cancer prognosis marker TP53R249S by ddPCR (double-stranded polymerase chain reaction) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180126 |
|
WD01 | Invention patent application deemed withdrawn after publication |